Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
Kwangsik Nho(Indiana University School of Medicine), Rima Kaddurah‐Daouk(Duke University), Cornelia M. van Duijn(King Abdulaziz University), Shannon L. Risacher(Indiana University School of Medicine), John Q. Trojanowski(California University of Pennsylvania), Gregory Louie(Duke University), Andrew J. Saykin(Indiana University School of Medicine), Rebecca Baillie(Rosa (United States)), Guoxiang Xie(University of Hawaiʻi at Mānoa), Gabi Kastenmüller(Helmholtz Zentrum München), Siamak MahmoudianDehkordi(Duke University), Matthias Arnold(Duke University), Thomas Hankemeier(Leiden University), Wei Jia(Hong Kong Virtual University), Xianlin Han(The University of Texas at San Antonio Health Science Center), Shahzad Ahmad(Boston University), Leslie M. Shaw(University of Pennsylvania), Michael W. Weiner(San Francisco VA Medical Center), Colette Blach(Duke University), P. Murali Doraiswamy(Duke University), Alexandra Kueider‐Paisley(Duke University)
Cited by 340
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k